Development of standardization approaches for recombinant endolysin LYSECD7-based pharmaceutical substance
- Authors: Antonova N.P1,2, Vasina D.V1, Balabanyan V.U2, Gushchin V.A1,2
-
Affiliations:
- N.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation
- Lomonosov Moscow State University
- Issue: Vol 23, No 9 (2020)
- Pages: 3-8
- Section: Articles
- URL: https://journals.eco-vector.com/1560-9596/article/view/112776
- DOI: https://doi.org/10.29296/25877313-2020-09-01
- ID: 112776
Cite item
Abstract
Full Text
About the authors
N. P Antonova
N.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Lomonosov Moscow State University
Email: northernnatalia@gmail.com
Post-graduate Student, Research Scientist Moscow
D. V Vasina
N.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation
Email: d.v.vasina@gmail.com
Ph.D. (Biol.), Research Laboratory Assistant Moscow
V. U Balabanyan
Lomonosov Moscow State University
Email: bal.pharm@mail.ru
Dr.Sc. (Pharm.), Associate Professor Moscow
V. A Gushchin
N.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; Lomonosov Moscow State University
Email: wowaniada@gmail.com
Moscow
References
- Oliveira H., Sao-Jose C., Azeredo J. Phage-derived peptidoglycan degrading enzymes: challenges and future prospects for in vivo therapy. Viruses. 2018; 10(6): 292.
- Schmelcher M., Donovan D.M., Loessner M.J. Bacteriophage endolysins as novel antimicrobials. Future Microbiol. 2012; 7(10): 1147-71.
- Назаров П.А. Альтернативы антибиотикам: литические ферменты бактериофагов и фаговая терапия. Вестник РГМУ. 2018; 1: 5-15.
- Антонова Н.П., Балабаньян В.Ю., Ткачук А.П. Макаров В.В., Гущин В.А. Физико-химические свойства и противомикробная активность рекомбинантного фаголизина бактериофага kpp10, действующего на Pseudomonas aeruginosa. Вестник РГМУ. 2018; 1: 22-9.
- Lood R., Winer B.Y., Pelzek A.J. et al. Novel phage Lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model. Antimicrob. Agents Chemother. 2015; 59(4): 1983-91.
- Larpin Y., Oechslin F., Moreillon P. et al. In vitro characterization of PlyE146, a novel phage lysin that targets Gramnegative bacteria. PLoS ONE. 2018; 13(2): e0192507.
- Antonova N.P., Vasina D.V., Lendel A.M. et al. Broad bactericidal activity of the Myoviridae bacteriophage lysins LysAm24, LysECD7, and LysSi3 against Gram-negative ESCAPE pathogens. Viruses. 2019; 11(3): e284.
- Государственная Фармакопея Российской Федерации XIV издания. М. 2018.
- Федеральный закон от 12.04.2010 №61-ФЗ «Об обращении лекарственных средств».